DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/s52986/ablation) has announced the addition of the "Ablation Catheters Market in Europe 2015-2019" report to their offering.
The ablation catheters market in Europe to grow at a CAGR of 10.14% over the period 2014-2019.
In Europe, approximately 11 million people are affected by cardiac arrhythmia, of which 6 million people are affected by atrial fibrillation. An ablation catheter aims to stop the irregular heart beat by removing the abnormal tissue responsible for causing the arrhythmia. It is a minimally invasive procedure usually performed under local anesthesia. The procedure involved one or more flexible catheters threaded through blood vessels into the heart. These catheters record the heart's electrical activity and identify the tissue responsible for the arrhythmia.
The report, Ablation Catheters Market in Europe 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the landscape of the ablation catheters market in Europe and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
According to the report, vendors are increasingly focusing on the development of new ablation tools to improve the efficacy of ablation procedures and patient safety. The new procedures are expected to further reduce procedure time. Catheter technologies have advanced tremendously during the past decade, from the simple 4 mm tip radiofrequency catheters to irrigated catheters with multielectrode recordings, shaft visualization, and contact force measurement. Alternatives to radiofrequency-based ablation procedures include cryoenergy-, cryoablation-, and laser-based ablation procedures.
Also, electrophysiologists and cardiac surgeons are interested in advanced products that demonstrate better efficiency, improved patient outcomes, and cost-effectiveness. Vendors and researchers are conducting studies on the cost-effectiveness of ablation procedures over antiarrhythmic drugs to showcase the effectiveness of their products and to obtain reimbursement, which will help increase the adoption and sale of their products.
Further, the report states that a lack of trained electrophysiologists is restricting the growth of the market in Europe.
- Biosense Webster
- Boston Scientific
- St. Jude Medical
Other prominent vendors
- Advanced Cardiac Therapeutics
- APT MEDICAL
- Edwards Lifesciences
- Hansen Medical
- Imricor Medical Systems
- Japan lifeline
- LEPU MEDICAL
- Melys AFSM
- PLC Medical Systems
For more information visit http://www.researchandmarkets.com/research/s52986/ablation